Last application date Jul 06, 2018 18:00
Department GE02 - Department of Pediatrics and medical genetics
Contract Limited duration
Degree master degree in a biomedical field, such as biotechnology, biochemistry, bio-engineering, biomedical sciences, pharmaceutical sciences or medicine
Occupancy rate 100%
Vacancy Type Research staff
While global survival of children with cancer is reaching up to 80%, cure rates remain disappointingly low for certain high-risk types of tumors and for most relapsed cases. Novel treatment approaches are urgently needed to further improve survival but also to reduce long term side effects. Translating novel, targeted therapies from the lab to the clinic remains challenging; often promising pre-clinical data cannot be translated in therapeutic improvements for the children with cancer. In this project, you will use the power of modern genomics techniques (RNA sequencing) to facilitate this translation. By discovering tumor response expression signatures in both in vitro (cell lines) and in vivo tumor model systems (murine xenografts) we hope to find biomarkers of therapy response in children treated with targeted therapies.
You are a highly motivated, critical and curious researcher with a keen interest in translational cancer research, willing to work in an international and multi-disciplinary research context. What you might lack in experience you make up for in eagerness to learn and introduce new techniques.
What we offer:
Ghent is ranked amongst the top cities to visit, with connections to London, Amsterdam, Paris in no time (https://visit.gent.be/en). A diverse local community with a range of housing options and many opportunities for eating out, movies, sports, etc.
Candidates can apply by sending their CV and letter of motivation to firstname.lastname@example.org before July 6th, 2018. Top-ranked candidates will be invited for an interview (either on site or via Skype). Start date is between Sept 1 and Oct 1, 2018.Continue reading